MedTrace Logo

European Quality Improvement Programme for Acute Coronary Syndromes

NCT00716430 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3500

Last updated 2008-07-16

No results posted yet for this study

Summary

The main hypothesis to be tested is that the use of a quality improvement programme will lead to measurable improvements in the management of care and use of evidence based treatments for patients presenting to hospital with non-ST elevation acute coronary syndromes.

Conditions

  • Acute Coronary Syndrome

Interventions

BEHAVIORAL

Quality Improvement Programme

Quality Improvement training programme

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-12-31
Completion
2009-02-28

Countries

  • France
  • Italy
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00716430 on ClinicalTrials.gov